A09-003 is a CDK9 inhibitor (IC50: 16 nM) that suppresses proliferation of leukemia cells (IC50 values of 1.90, 0.86, 2.49, 1.84, and 0.48 μM against BDCM, Molm-14, THP-1, U937, and MV4-11 cells, respectively); it induces apoptosis and downregulates Mcl-1 expression via dephosphorylation of Thr163.